Sharon Tetlow Dice Therapeutics, Inc. (DICE) insider trading activity

DICE Quotes by TradingView

Sharon Tetlow is Director of DICE Therapeutics, Inc.. Currently has a direct ownership of 0 shares of DICE, which is worth approximately $0. The most recent transaction as insider was on Aug 09, 2023, when has been sold 49,841 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

SHARON TETLOW Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2023
SELL
Sale (or disposition) back to the issuer
-
49,841 Reduced 100.0%
0 Common Stock

Also insider at

CBIO
CATALYST BIOSCIENCES, INC. Healthcare
Director
GPCR
Structure Therapeutics Inc.
ST

Sharon Tetlow

Director
South San Francisco, CA

Track Institutional and Insider Activities on DICE

Follow DICE Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DICE shares.

Notify only if

Insider Trading

Get notified when an Dice Therapeutics, Inc. insider buys or sells DICE shares.

Notify only if

News

Receive news related to DICE Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DICE